Literature DB >> 25398255

Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Mireia Alcalde1, Oscar Campuzano, Georgia Sarquella-Brugada, Elena Arbelo, Catarina Allegue, Sara Partemi, Anna Iglesias, Antonio Oliva, Josep Brugada, Ramon Brugada.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy is an inherited cardiac entity characterized by right ventricular, or biventricular, fibrofatty replacement of myocardium. Structural alterations may lead to sudden cardiac death, mainly in young males during exercise. Autosomal dominant pattern of inheritance is reported in most parts of pathogenic genetic variations identified. Currently, 13 genes have been associated with the disease but nearly 40 % of clinically diagnosed cases remain without a genetic diagnosis. New genetic technologies allow further genetic analysis, generating a significant amount of genetic data in novel genes, which is often classified as of ambiguous significance. We focus on genetic advances of arrhythmogenic right ventricular cardiomyopathy, helping clinicians to interpret and translate genetic data into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398255     DOI: 10.1007/s00392-014-0794-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  117 in total

1.  A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Paul A van der Zwaag; Jan D H Jongbloed; Maarten P van den Berg; Jasper J van der Smagt; Roselie Jongbloed; Hennie Bikker; Robert M W Hofstra; J Peter van Tintelen
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

Review 2.  Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy.

Authors:  A Angelini; C Basso; A Nava; G Thiene
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

3.  Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives.

Authors:  Hanno L Tan; Nynke Hofman; Irene M van Langen; Allard C van der Wal; Arthur A M Wilde
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

4.  Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation.

Authors:  Nicola Carboni; Claudia Sardu; Eleonora Cocco; Giovanni Marrosu; Rosa C Manzi; Vincenzo Nissardi; Franco Isola; Anna Mateddu; Elisabetta Solla; Maria A Maioli; Valentina Oppo; Rachele Piras; Giancarlo Coghe; Carlo Lai; Maria G Marrosu
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

5.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

6.  Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders?

Authors:  Alex Hørby Christensen; Marianne Benn; Anne Tybjaerg-Hansen; Stig Haunso; Jesper Hastrup Svendsen
Journal:  Cardiology       Date:  2009-12-03       Impact factor: 1.869

7.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

8.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

9.  Age-dependent clinical and genetic characteristics in Japanese patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Seiko Ohno; Iori Nagaoka; Megumi Fukuyama; Hiromi Kimura; Hideki Itoh; Takeru Makiyama; Akihiko Shimizu; Minoru Horie
Journal:  Circ J       Date:  2013-03-20       Impact factor: 2.993

10.  Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications.

Authors:  M Alcalde; O Campuzano; C Allegue; M Torres; E Arbelo; S Partemi; A Iglesias; J Brugada; A Oliva; A Carracedo; R Brugada
Journal:  Int J Legal Med       Date:  2014-05-16       Impact factor: 2.686

View more
  6 in total

1.  Limitations in S-ICD therapy: reasons for system explantation.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-07-07       Impact factor: 5.460

Review 2.  Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.

Authors:  Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2017-08-24       Impact factor: 5.460

3.  Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Andreas Löher; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-08-02       Impact factor: 5.460

4.  Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Simon Kochhäuser; Markus Bettin; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  J Interv Card Electrophysiol       Date:  2016-05-23       Impact factor: 1.900

5.  LINC00680 and TTN-AS1 Stabilized by EIF4A3 Promoted Malignant Biological Behaviors of Glioblastoma Cells.

Authors:  Wei Tang; Di Wang; Lianqi Shao; Xiaobai Liu; Jian Zheng; Yixue Xue; Xuelei Ruan; Chunqing Yang; Libo Liu; Jun Ma; Zhen Li; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-16       Impact factor: 8.886

6.  Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?

Authors:  Gerrit Frommeyer; Sven Zumhagen; Dirk G Dechering; Robert Larbig; Markus Bettin; Andreas Löher; Julia Köbe; Florian Reinke; Lars Eckardt
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.